Wang et al. (53) reported that SA inhibited kidney inflammation and fibrosis via decreasing the expression of NF-κB and enhancing the expression of total NF-κB inhibitor alpha (IκBα), thus preventing the progression of diabetic kidney disease. Here, NFKB1 is linked to diabetic kidney disease.